Todd Martinsky - Arrayit Director

ARYC Stock  USD 0.0001  0.00  0.00%   

Director

Mr. Todd J. Martinsky serves as Vice President, Director of Arrayit Corporationration Todd received a Bachelor of Arts degree from San Jose State University, after which he served as Director of Education and Consulting at the Codd and Date Consulting Group, whose founder was famous for creating the relational database. Todd cofounded TeleChem International, Inc. in 1993, and oversaw the Arrayit biotech division beginning in 1996. His computer science consulting experience had measurable impact on the evolution of Arrayits business, as he led the design, development and implementation of the Companys online presence and related ecommerce platform the first of its kind in the biotech sector. He has presented as a Keynote Speaker for key microarray workshops and scientific meetings and has served on various microarray manufacturing panels. Over the past decade, Todd has served as a guest speaker at events sponsored by the Centers for Disease Control, The United States Department of Agriculture, and a number of universities. Serving as an advisor to the U.S. Pharmacopeia, he authored a chapter for a compendium on nucleic acid test methods for which he received Doctorallevel recognition. In addition, Todd has authored chapters on microarray manufacturing methods for five books, including the new 2009 Microarray Methods and Protocols . On the web, he authors and manages a popular microarray blog and is a respected member of the emailbased microarray GeneArrays List Serve. Todd was recognized as the number one mostquoted microarray executive through Arrayits educational outreach program, appearing in numerous feature articles and scientific publications. since 2008.
Age 59
Tenure 16 years
Professional MarksPh.D
Address 927 Thompson Place, Sunnyvale, CA, United States, 94085
Phone408-744-1331
Webhttps://www.arrayit.com

Arrayit Management Efficiency

The company has return on total asset (ROA) of (2.104) % which means that it has lost $2.104 on every $100 spent on assets. This is way below average. Arrayit's management efficiency ratios could be used to measure how well Arrayit manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -3.13. In addition to that, Return On Capital Employed is expected to decline to 0.61. At present, Arrayit's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 38.90, whereas Total Assets are forecasted to decline to about 989.9 K.
Arrayit currently holds 250 K in liabilities. Arrayit has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Arrayit's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Jan ReedStepan Company
61
Joaquin DelgadoStepan Company
61
Loreto SilvaBarrick Gold Corp
55
Gustavo CisnerosBarrick Gold Corp
74
Baiqing HeYuexiu Transport Infrastructure
58
Andrew QuinnBarrick Gold Corp
66
Gregory LawtonStepan Company
70
Brian GreenspunBarrick Gold Corp
73
Edward WehmerStepan Company
67
Randall DearthStepan Company
57
Ronald HaddockDelek Logistics Partners
81
Sherri BrillonDelek Logistics Partners
61
Gennifer KellyDelek Logistics Partners
48
Francis DAndreaDelek Logistics Partners
66
Yoseph BornsteinMicrobot Medical
65
Lorinda BurgessStepan Company
58
Michael BoyceStepan Company
72
Charles BrownDelek Logistics Partners
73
Eric GaddDelek Logistics Partners
65
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. ARRAYIT CORP operates under Diagnostics Research classification in the United States and is traded on PNK Exchange. It employs 7 people. Arrayit (ARYC) is traded on OTCCE Exchange in USA and employs 7 people. Arrayit is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Arrayit Leadership Team

Elected by the shareholders, the Arrayit's board of directors comprises two types of representatives: Arrayit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arrayit. The board's role is to monitor Arrayit's management team and ensure that shareholders' interests are well served. Arrayit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arrayit's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Schena, Chairman, CEO and CFO
Mark Schena, President, Chief Science Officer, Treasurer, Secretary, Scientific Advisor and Director
Paul Haje, Vice Marketing
Ronald Cole, Consultant
Todd Martinsky, Founder, Executive VP, Scientific Advisor and Director
William Sklar, Financial Consultant

Arrayit Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arrayit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Arrayit offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arrayit's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arrayit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arrayit Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrayit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Arrayit Stock refer to our How to Trade Arrayit Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrayit. If investors know Arrayit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrayit listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.015
Quarterly Revenue Growth
0.249
Return On Assets
(2.10)
The market value of Arrayit is measured differently than its book value, which is the value of Arrayit that is recorded on the company's balance sheet. Investors also form their own opinion of Arrayit's value that differs from its market value or its book value, called intrinsic value, which is Arrayit's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrayit's market value can be influenced by many factors that don't directly affect Arrayit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrayit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrayit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrayit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.